Guangzhou Medcan Pharmatech Ltd. Details
- Country/Region:China
- Province/State:Guangdong
- City:GuangZhou
- Operational Address:Self-Compiled Rm. 201, 2/F, Building J1, No. 1, Jiantashan Rd., Science City, Guangzhou, Guangdong, China (Mainland)
- Business Type:Trading Company
- Year Established:2011
- Year Start Exporting:2011
- Number Of Employees:11 - 50 People
- Total Revenue:US$2.5 Million - US$5 Million
- Average Lead Time:15 Day(s)
- Trade Capacity:South Asia : 30.00% South America : 30.00%
- Production Capacity:- -
- R&D Capacity:No. of R&D Staff :5 - 10 People
- Main Products:Food Additives Glycine, L-Asparaganase-APIs, Orlistat-APIs, Cyclosporin A-APIs, Tacrolimus-APIs, Solvent,Food Additive,Intermediate,APIs
- Address:Building J1,Jiantashan Rd,GuangZhou Science City
- Main Markets:South Asia, South America, Eastern Europe, Western
- Location:Guangdong, China (Mainland)
- Website:Visit website
About Us
- Guangzhou Medcan Pharmatech Ltd. is a high-tech company engaged in the development, sales and research and development of new biopharmaceutical product, genetic engineering, bioinformatics and other areas. The registered capital is five million RMB. Guangzhou Medcan Pharmatech Ltd. has established a strategic alliance with more than 10 domestic and foreign pharmaceutical biotechnology universities. Currently, our company's product research and development ability is the forefront of domestic and related fields. In China, our company also received the support from Guangzhou Yuan Tong Pharmaceutical Co., Ltd. and South China Normal University. Our company has developed a partnership with the Guangdong Medical College and South China Drug Discovery Centre.
Our company has 18 employees, including 4 doctors, 6 masters and 2 pharmacists, with excellent R & D team, strong technical force, a dynamic management mechanism, first-class management talent and a good financing channel. Our company is perfectly capable of developing new drugs and advancing technology into economic benefits, to achieve social benefits.
Our employees have extensive experience in the synthesis of small molecule drugs and microbial fermentation. In pharmaceutical preparations, our company has developed a variety of dosage forms, including some new formulations such as liquid capsules, controlled release and targeted drug delivery systems. Our company has a wealth of export agents of registered technology, and drug product registration experience of exporting to the EU, the United States, Cuba, Brazil and India. Our company has established a comprehensive library of fermentation bacteria, with dozens of drugs bacteria fermentation species, such as erythromycin, daptomycin, Nepal, the Secretary and a full set of statins and other bacteria fermentation process.
- Shandong Tonghui Biotechnology Co., Ltd.
- Beijing Minsheng Stockraising Co., Ltd.
- Bevenovo Co.,Limited
- Shanghai BaiLun Biotechnology Co., Ltd.
- Lianyungang Tuwei International Trade Co., Ltd
- Ningxia Unisplendour Tianhua Methionine Co., Ltd.
- Guangdong Yunhua Industrial Co., Ltd.
- Henan Siwei Biotechnology Co., Ltd.
- Xinjiang Fufeng Biotechnologies Co., Ltd
- Kunming Yunpanshan Phosphorus Chemicals Co., Ltd.
Category
Related Product